北京同仁堂集团致歉！

Core Viewpoint - Beijing Tongrentang Group issued an apology regarding the Antarctic krill oil incident, emphasizing a zero-tolerance policy towards brand management and consumer protection [2][3]. Group 1: Actions Taken by the Company - A special task force has been dispatched to Sichuan to conduct a thorough investigation of the involved products [3]. - The company has ordered the immediate removal of the implicated products from the market and will ensure compensation to consumers as per regulatory requirements [4]. - Legal actions will be pursued against Sichuan Health, Habao Pharmaceutical, and related e-commerce platforms for trademark infringement and misleading consumers [4]. - Accountability measures will be implemented for Sichuan Health and its parent company regarding operational and management issues [4]. Group 2: Brand Protection Initiatives - A comprehensive review of brand usage violations across all subsidiaries will be conducted [5]. - A brand cleanup initiative will be launched to eliminate improper use of the "Tongrentang" name and ensure compliance with brand management standards [6]. - E-commerce platform stores will be required to strictly use the "Tongrentang" double-dragon logo to help consumers identify legitimate purchasing channels [7]. Group 3: Incident Background - A product labeled as "Beijing Tongrentang 99% High Purity Antarctic Krill Oil" was found to falsely claim high phospholipid content, with actual testing revealing a phospholipid content of 0% [7]. - The implicated product was produced by Anhui Habao Pharmaceutical and distributed by Sichuan Tongrentang Health, which is not a direct subsidiary of Beijing Tongrentang [7][10]. - The company clarified that it focuses on the production and sale of traditional Chinese medicine, with over 400 product specifications, and does not outsource production to third parties [10].